Atlas Trials

Novel 99mTc-labeled Somatostatin Antaginosts in the Diagnostic Algotithm of Neuroendocrine Neoplasms

Clinical trial NCT05871320 · COMPLETED

Trial details

NCT number
NCT05871320
Sponsor
Jagiellonian University
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2022-12-23
Primary completion
2023-06-30
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.